BS&F Obtains $64m Settlement for Class in Tracking Stock Litigation

Genzyme to Pay $64m to Settle Buyback Claims

The Boston Globe, August 10, 2007
Jeffrey Krasner

Reporting that litigation between Genzyme Corporation and former shareholders involving use of "tracking stock" has settled. Genzyme will pay the plainitff class $64 million in cash subject to approval by the Court. BS&F acted as lead counsel to the Class in the long running dispute.

Related Lawyers: Jonathan Sherman, Jonathan M. Shaw, Dara Burns,

Related Practices: Securities Litigation, Class Actions, Litigation

External Link: http://www.boston.com/business/technology/biotechnology/artic...